PLoS ONE (Jan 2024)

Non-fibril form but not fibril form of human islet amyloid polypeptide 8-20 changes brain functions in mice.

  • Hinaho Suginoma,
  • Ryuji Owada,
  • Akiko Katano-Toki,
  • Ayaka Mori,
  • Jun Fujioka,
  • Kazuhiro Nakamura

DOI
https://doi.org/10.1371/journal.pone.0296750
Journal volume & issue
Vol. 19, no. 1
p. e0296750

Abstract

Read online

Whether fibril formation increases or decreases cytotoxicity remains unclear. Aggregation of human islet amyloid polypeptide (hIAPP), a pivotal regulator of glucose homeostasis, impairs the function and viability of pancreatic β cells. Evidence suggests that low-order oligomers of hIAPP are more toxic to β cells than fibril. However, it remains unclear whether non-fibril form of hIAPP specifically alters brain functions. This study produced fibril and non-fibril forms from a single hIAPP 8-20 peptide. The non-fibril form-injected mice showed changes in spontaneous motor activities, preference for location in the open field and social behavior. In contrast, the fibril-injected mice showed no changes in these behavioral tests. In line with the behavioral changes, the non-fibril form led to impaired neurite outgrowth of cultured neuron-like cells and the loss of neurons in the mouse hippocampus. These findings suggest that non-fibril form but not fibril form of hIAPP changes brain functions.